Blueberry Therapeutics completes BB2603 Investigator meeting
The Blueberry Therapeutics project team along with CEO John Ridden, and their partner Iqvia Biotech, held an Investigator meeting in Vienna, Austria on November 8th 2019. The meeting was attended by over 50 site staff from both private and hospital based dermatology clinics across Poland, Czech Republic and Germany, and was the first opportunity for